Clinical Manifestation and Outcomes of Thrombolytic and Consevative Therapy in Covid-19 Patients with ST-Segment Elevation Pattern: A Case Series
Versions
- 2021-09-30 (2)
- 2021-09-30 (1)
Downloads
COVID-19 pandemic has become a global issues, especially involving cardiovascular diseases. The management of COVID-19 patients with ST-Segment elevation in early pandemic era faces new challenges. Challenges can occur in term of patient's delay and healthcare safety. This case series discussed clinical manifestations, examination findings, alternative strategies including thrombolytic and conservative therapy, and patients' outcomes.
Daniels M.J., Cohen M.G., Bavry A.A., Kumbhani D.J. 2020. Reperfusion of STEMI in the COVID-19 era-business as usual? Circulation 141:1948–1950
Lauren S. R., Sahil A.P., Ajay J.K. 2020. COVID-19 Spesific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China. J Am Coll Cardiol 76(11)1325-1327
Pinto D. 2020. COVID-19: Myocardial infarction and other coronary artery disease issues. Uptodate.searchbox.science.
Welt F.G., Shah P.B., Aronow H.D., et al. 2020. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC's Interventional Council and SCAI. J Am Coll Cardiol 75:2372–2375
- Cardiovascular and Cardiometabolic Journal (CCJ) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
-
Authors who publish with Cardiovascular and Cardiometabolic Journal (CCJ) agree to the following terms:
-
The journal allows the author to hold the copyright of the article without restrictions.
-
The journal allows the author(s) to retain publishing rights without restrictions.
-
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA).
